REDEFINING MONOCLONAL ANTIBODY THERAPY

Welcome to the Brand page for “REDEFINING MONOCLONAL ANTIBODY THERAPY”, which is offered here for Medical information services rendered to the public by means of a global computer information network, pertaining to cancer, cancer research, treatment of cancer, pharmaceutical preparations for treatment of cancer, vaccines and diagnostic preparations;monoclonal antibody therapy;.

Its status is currently believed to be active. Its class is unavailable. “REDEFINING MONOCLONAL ANTIBODY THERAPY” is believed to be currently owned by “IMCLONE SYSTEMS INCORPORATED”.

Owner:
IMCLONE SYSTEMS INCORPORATED
Owner Details
Description:
MEDICAL INFORMATION SERVICES RENDERED TO THE PUBLIC BY MEANS OF A GLOBAL COMPUTER INFORMATION NETWORK, PERTAINING TO CANCER, CANCER RESEARCH, TREATMENT OF CANCER, PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER, VACCINES AND DIAGNOSTIC PREPARATIONS;MONOCLONAL ANTIBODY THERAPY;
Categories: MEDICAL INFORMATION SERVICES RENDERED